StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Rockwell Medical's price to sales ratio was 4.1× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.1× to 4.9×, with a median of 0.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.1×+3.6
2025Dec 31, 20250.4×−0.2
2024Dec 31, 20240.7×+0.0
2023Dec 29, 20230.7×+0.5
2022Dec 30, 20220.2×−0.5
2021Dec 31, 20210.6×−0.9
2020Dec 31, 20201.5×−1.0
2019Dec 31, 20192.5×+0.6
2018Dec 31, 20181.9×−3.5
2017Dec 29, 20175.4×−0.9
2016Dec 30, 20166.2×−3.0
2015Dec 31, 20159.2×+1.4
2014Dec 31, 20147.9×−0.3
2013Dec 31, 20138.1×+5.0
2012Dec 31, 20123.1×+0.0
2011Dec 30, 20113.0×–

More Rockwell Medical figures

See a number that looks wrong?